alere testpack+plus hcg urine with on board controls pregnancy test kit
alere ltd - anti-alpha tsh monoclonal antibody, anti-beta hcg monoclonal antibody, goat polyclonal antibody to bovine igg - pregnancy test kit
betaferon
bayer new zealand limited - interferon beta-1b 0.25mg (20% excess in quantity filled) - injection with diluent - 8 miu - active: interferon beta-1b 0.25mg (20% excess in quantity filled) excipient: albumin hydrochloric acid mannitol sodium hydroxide hydrochloric acid sodium chloride water for injection - betaferon is indicated for: · the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded, · the treatment of ambulatory patients, with relapsing-remitting multiple sclerosis characterised by at least two attacks of neurological dysfunction over a two year period followed by complete or incomplete recovery. · the reduction of frequency and severity of clinical relapses and for slowing the progression of disease in patients with secondary progressive multiple sclerosis
betaferon
bayer israel ltd - interferon beta 1b - powder and solvent for solution for injection - interferon beta 1b 0.3 mg/vial - interferon beta-1b - interferon beta-1b - use in ambulatory patients with relapsing-remitting multiple sclerosis (rrms) and relapsing progressive m.s. to reduce the frequency of clinical exacerbations. treatment of secondary progressive (sp) form of multiple sclerosis. treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of mri abnormalities characteristic of m.s. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.
betaferon
bayer ag - interferon beta-1b - multiple sclerosis - immunostimulants, - betaferon is indicated for the treatment ofpatients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.
betaferon interferon beta-1b rbe 0.25mg (8 million iu) powder for injection vial with diluent syringe
bayer australia ltd - interferon beta-1b, quantity: 0.25 mg/ml - injection, powder for - excipient ingredients: albumin; mannitol - betaferon is indicated for the treatment of: - ambulatory patients with relapsing-remitting multiple sclerosis (ms) characterised by at least two attacks of neurologic dysfunction over a two year period followed by complete or incomplete recovery. - betaferon is also indicated for the reduction of frequency and severity of clinical relapses, and for the slowing of progression of disease in patients with secondary progressive multiple sclerosis. - the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.
guna-anti il 1- anti-interleukin-1.alpha. immunoglobulin g rabbit- canakinumab solution/ drops
guna spa - anti-interleukin-1.alpha. immunoglobulin g rabbit (unii: ml4qrz1hcl) (anti-interleukin-1.alpha. immunoglobulin g rabbit - unii:ml4qrz1hcl), canakinumab (unii: 37cq2c7x93) (canakinumab - unii:37cq2c7x93) - anti-interleukin-1.alpha. immunoglobulin g rabbit 4 [hp_c] in 30 ml - anti interleukin 1 alpha 4c acute pain and fever relief anti interleukin 1 beta 4c acute pain and fever relief temporary relief of: - acute pain - fever take 15 minutes before meals.
antizol fomepizole 1.5g/1.5ml concentrated injection vial
aft pharmaceuticals pty ltd - fomepizole, quantity: 1 g/ml - injection - excipient ingredients: - antizol is indicated for the treatment of ethylene glycol or methanol poisoning. (see dosage and administration).
juroclav 500 broad spectrum antibiotic tablets
zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 400.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 100.0 mg/tb - antibiotic & related - calf | dog | beef calf | bitch | bovine | calf - poddy | calf - preweaning | calf - sucker | castrate | dairy calf | neonatal ca - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria
juroclav 250 broad spectrum antibiotic tablets
zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 200.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 50.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria
juroclav 50 broad spectrum antibiotic tablets
zoetis australia pty ltd - amoxycillin as amoxycillin trihydrate; clavulanic acid as potassium clavulanate - oral tablet - amoxycillin as amoxycillin trihydrate antibiotic active 40.0 mg/tb; clavulanic acid as potassium clavulanate antibiotic active 10.0 mg/tb - antibiotic & related - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - antibiotics - oral, parenteral | bacterial infection | airsacculitis | amoxycillin sensitive bacteria | anaerobic bacterial infection | associated with viral disease | avian mycoplasmas | clavulanic acid sensitive | coccidiosis | coryza | crd | dermatoses | diarrhoea | endometritis | enteritis | enzootic pneumonia | escherichia coli | european brood disease | gentamicin sensitive | gram negative organisms | gram positive organisms | hypermotility | infected wounds | infections | lactating | mastitis | post parturient bacterial infe | primary bacterial infection | protozoal infections | pyometra | salmonellosis | sinusitis | sulfadiazine sensitive bacteri | systemic bacterial infection | trimethoprim sensitive bacteri | tylosin sensitive bacteria